Cosmetic Botulinum Toxin From a Pharmacological Point of View

dc.contributor.advisorPórszász, Róbert
dc.contributor.advisordeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.contributor.authorChao, Cynthia Hsin Ya
dc.contributor.departmentDE--Általános Orvostudományi Karhu_HU
dc.contributor.opponentDrimba, László
dc.contributor.opponentSzentmiklósi, József András
dc.contributor.opponentdeptKenézy Kórház, Központi Aneszteziológiai és Intezív Terápiás Osztályhu_HU
dc.contributor.opponentdeptDebreceni Egyetem::Általános Orvostudományi Kar::Farmakológiai és Farmakoterápiai Intézethu_HU
dc.date.accessioned2022-08-15T09:09:15Z
dc.date.available2022-08-15T09:09:15Z
dc.date.created2021-04-23
dc.description.abstractBotulinum toxin has long been proven as an effective and safe drug to diminish the appearance of wrinkles while causing limited adverse effects. Aside from the four approved FDA botulinum type A toxins, there are emerging formulations undergoing clinical trials as well as multiple biosimilars in Asia. Due to the nature of manufacturing process and reconstitution, these drugs have different levels of efficacy, duration of action, and effects on different muscles in the body. This paper will discuss the current botulinum toxin products on the market and under trial, make the comparison between intramuscular and intradermal techniques, and illustrate the future potential of botulinum toxin in aesthetic medicine.hu_HU
dc.description.correctorhbk
dc.description.courseáltalános orvoshu_HU
dc.description.courselangangolhu_HU
dc.description.degreeegységes, osztatlanhu_HU
dc.format.extent41hu_HU
dc.identifier.urihttp://hdl.handle.net/2437/336456
dc.language.isoenhu_HU
dc.subjectaesthetic medicinehu_HU
dc.subjectoff-label therapyhu_HU
dc.subjectbotulinum toxinhu_HU
dc.subjectbiosimilarshu_HU
dc.subject.dspaceDEENK Témalista::Orvostudomány::Farmakológiahu_HU
dc.titleCosmetic Botulinum Toxin From a Pharmacological Point of Viewhu_HU
Fájlok